Academia.eduAcademia.edu

Outline

Title
Abstract
Methods for Measuring Obesity
Materials and Methods
Participants and Analyses (Papers III and IV)
Statistics
Experimental Studies (Papers I and II)
Results
Discussion
Summary
General Discussion
References

Environmental Contaminants and Obesity

Profile image of MAGNUS RÖNNMAGNUS RÖNN

2013

Abstract

Obesity is a worldwide problem affecting both children and adults. Genetic, physiological, environmental, psychological, social and economic factors interact in varying degrees, influencing body weight and fat distribution and the progress of obesity. Moreover, some anthropogenic chemicals have proven to be endocrine disrupting chemicals (EDCs) with the potential to interfere with different actions of hormones in the body. EDCs may thereby disrupt homeostasis, modifying developmental, behavioral and immune functions in humans and animals, and also promoting adiposity. Because hormones generally act at low concentrations, small changes in the endocrine system may lead to extensive effects. Based on data from experimental and epidemiological studies this thesis elucidates the relationship between a large number of environmental contaminants and obesity. The experimental studies demonstrated that fructose supplementation in the drinking water resulted in unfavorable metabolic alterations such as a higher liver somatic index (LSI), an increase in plasma triglycerides and increased plasma levels of apo A-I. Fructose in combination with exposure to bisphenol A (BPA) increased liver fat content and plasma levels of apo A-I in juvenile female Fischer 344 rats. The experimental studies also showed that the retro-peritoneal fat, which in rats is a distinct fat depot easy to distinguish and dissect, correlated well with the measurements of total fat mass analyzed with MRI, and could therefore be used as a substitute for total fat mass in rats. The epidemiological studies showed that circulating levels of persistent organic pollutants (POPs) were related to fat mass measured by DXA. OCDD, HCB, TNC, DDE and the less chlorinated PCBs were positively related to fat mass, while the more highly chlorinated PCBs showed a negative association. Further, circulating levels of BPA were positively associated with levels of the hormones adiponectin and leptin, but negatively related with ghrelin, hormones which are involved in the regulation of hunger and satiety. However, serum BPA levels were not related to measures of fat mass in the elderly individuals in the PIVUS cohort. This thesis concludes that environmental contaminants such as BPA and POPs most likely are contributors, along with genetic, social and behavioral factors, to the development of obesity.

Related papers

Impact of environmental endocrine disrupting chemicals on the development of obesity
Retha Newbold

Hormones (Athens, Greece)

Environmental chemicals with hormone-like activity can disrupt programming of endocrine signaling pathways during development and result in adverse effects, some of which may not be apparent until much later in life. Recent reports link exposure to environmental endocrine disrupting chemicals during development with adverse health consequences, including obesity and diabetes. These particular diseases are quickly becoming significant public health problems and are fast reaching epidemic proportions worldwide. This review summarizes data from experimental animals and humans which support an association of endocrine disrupting chemicals, such as diethylstilbestrol, bisphenol A, phytoestrogens, phthalates, and organotins, with the development of obesity. Potential mechanisms are summarized and future research needs are discussed.

View PDFchevron_right
Obesityand metabolic comorbidities: environmental diseases?
Carla Lubrano

Obesity and metabolic comorbidities represent increasing health problems. Endocrine disrupting compounds (EDCs) are exogenous agents that change endocrine function and cause adverse health effects. Most EDCs are synthetic chemicals; some are natural food components as phytoestrogens. People are exposed to complex mixtures of chemicals throughout their lives. EDCs impact hormone-dependent metabolic systems and brain function. Laboratory and human studies provide compelling evidence that human chemical contamination can play a role in obesity epidemic. Chemical exposures may increase the risk of obesity by altering the differentiation of adipocytes. EDCs can alter methylation patterns and normal epigenetic programming in cells. Oxidative stress may be induced by many of these chemicals, and accumulating evidence indicates that it plays important roles in the etiology of chronic diseases. The individual sensitivity to chemicals is variable, depending on environment and ability to metabolize hazardous chemicals. A number of genes, especially those representing antioxidant and detoxification pathways, have potential application as biomarkers of risk assessment. The potential health effects of combined exposures make the risk assessment process more complex compared to the assessment of single chemicals. Techniques and methods need to be further developed to fill data gaps and increase the knowledge on harmful exposure combinations.

View PDFchevron_right
Role of Environmental Chemicals in Obesity: A Systematic Review on the Current Evidence
Parinaz Poursafa

Journal of Environmental and Public Health, 2013

The purpose of this paper is to systematically review the experimental and human studies on obesogenic chemicals and their mechanisms of action to provide a comprehensive view on the multifactorial aspects of obesity. The literatures were searched in available databases. The relevant papers were selected in three phases. After quality assessment, two reviewers extracted the data while another checked their extracted data. In this review, we summarized information regarding environmental chemicals that can be associated with obesity. Most evidence comes from experimental and laboratory studies; however a growing number of human studies also support the role of obesogenic chemicals. The current evidence proposes that the systemic responses to exposure to environmental factors could potentially increase the risk of excess weight. The effects of exposure to these chemicals are of crucial importance during developmental phases of life, when preprogramming for an adipogenic outcome may oc...

View PDFchevron_right
Review Article Obesity and Metabolic Comorbidities: Environmental Diseases?
Stefania Mariani

Oxidative medicine and cellular longevity

Obesity and metabolic comorbidities represent increasing health problems. Endocrine disrupting compounds (EDCs) are exogenous agents that change endocrine function and cause adverse health effects. Most EDCs are synthetic chemicals; some are natural food components as phytoestrogens. People are exposed to complex mixtures of chemicals throughout their lives. EDCs impact hormone-dependent metabolic systems and brain function. Laboratory and human studies provide compelling evidence that human chemical contamination can play a role in obesity epidemic. Chemical exposures may increase the risk of obesity by altering the differentiation of adipocytes. EDCs can alter methylation patterns and normal epigenetic programming in cells. Oxidative stress may be induced by many of these chemicals, and accumulating evidence indicates that it plays important roles in the etiology of chronic diseases. The individual sensitivity to chemicals is variable, depending on environment and ability to metab...

View PDFchevron_right
Obesity, Persistent Organic Pollutants and Related Health Problems
Loukia Vassilopoulou

Obesity and Lipotoxicity, Advances in Experimental Medicine and Biology, Springer International Publishing, Cham, Switzerland: Springer, 2017

The present review aims to delve into persistent organic pollutants (POPs), as xenobiotics, in correlation to human health. POPs exhibit a group of common characteristics, including lipophilicity, persistence to decomposition and bioaccumulation in tissues. POPs have been thoroughly studied by former researchers, as they offer a particular interest in the elucidation of metabolic, endocrine and immune perturbation caused by their synergy with intracellular mechanisms. Herein particular focus is attributed to the relationship of POPs with obesity provocation. Obesity nowadays receives epidemic dimensions, as its prevalence elevates in an exponential degree. POPs-induced obesity rotates around interfering in metabolic and endocri-nal procedures and interacting with peroxisome-proliferator and retinoic receptors. Moreover, polymorphisms in CYP gene families exert a negative result, as they incapacitate detoxification of POPs. Obesity could be deemed as a multidimensional condition, as various factors interact to lead to an obesogenic result. Therefore, concomitant disorders may occur, from mild to lethal, and get intensified due to POPs exposure. POPs exact function mechanisms remain rather enigmatic, thus further investigation should be prospectively performed, for a more lucid picture of this issue, and, consequently for the establishment of alternative solutions.

View PDFchevron_right
Bisphenol-A and Risk of Obesity Among A Sample of Egyptian Children: Role of Adiponectin as Biomarker of Exposure
Hend Abo El-Atta

Mansoura Journal of Forensic Medicine and Clinical Toxicology

Bisphenol-A (BPA) is one of the commonest chemicals used in the manufacturing of plastics. Childhood obesity is one of the most serious public health challenges of the 21 st century that affects many low-and middle-income countries, including Egypt. This study was conducted to correlate between BPA exposure and risk of obesity in a sample of Egyptian children and to find out whether adiponectin (ADP) can be utilized as an exposure biomarker or not. This study was conducted on 80 children. They were divided into two groups according to their body mass index (BMI): Study group included 40 obese children (BMI ≥ 95 th percentile), and control group included 40 normal-weight children (BMI 5 th-85 th percentile). Levels of urinary BPA and serum ADP were estimated using HPLC and ELISA respectively. The study revealed that statistically significant increase in mean adjusted urinary BPA levels (P < 0.001) and serum ADP levels (P < 0.001) between study and control groups. Within the study group, a statistically significant positive correlation was found between urinary BPA levels and BMI (r = 0.956), meanwhile, statistically significant negative correlations were found between urinary BPA levels and serum ADP levels, as well, serum ADP levels and BMI (r=-0.947,-0.984 respectively). Binary logistic regression analysis showed that odds ratio for serum ADP level was 0.146 with 95% CI: 0.003-0.66, P=0.012. Significant increased risk for obesity among BPA exposed children was found and ADP can be used as a predictor biological marker for BPA-induced obesity.

View PDFchevron_right
Differential effects of environmental chemicals and food contaminants on adipocyte differentiation, biomarker release, and PPARα/γ activation
C. Nellemann

Reproductive Toxicology, 2011

Eleven environmental relevant chemicals were investigated for their ability to affect adipogenesis in vitro, biomarker release from adipocytes and PPARa and c activation. We found that butylparaben stimulated adipogenesis in 3T3-L1 adipocytes and increased release of leptin, adiponectin and resistin from the cells. Butylparaben activated PPARc as well, which may be a mediator of the adipogenic effect. Polychlorinated biphenyl (PCB)153 also stimulate adipogenesis and biomarker release, but did not affect PPARs. The data indicates that PPARc activating chemicals often stimulate adipocyte differentiation although PPARc activation is neither a requirement nor a guarantee for stimulation. Four out of the eleven chemicals (bisphenol A, mono-ethylhexyl phthalate, butylparaben, PCB 153) caused increased adipogenesis. The release of adipocyte-secreted hormones was sometimes but not always correlated with the effect on adipocyte differentiation. Eight chemicals were able to cause increased leptin release. These findings strengthen the hypothesis that chemicals can interfere with pathways related to obesity development.

View PDFchevron_right
Obesity and obesity-related diseases: A consequence of our man-made chemical environment?
Luc Van Gaal

Health, 2012

The prevalence of obesity and its related disorders is currently attaining pandemic proportions, both in the Western and the developing world. Although lifestyle choices are commonly accepted as the main reasons, it has recently been suggested that environmental pollutants may provide an alternative cause. Several man-made chemicals have been shown to facilitate the differentiation into adipocyte at environmentally relevant levels. This process is mediated through different nuclear receptors. The endocrine function of the adipocyte itself is also affected by chemicals. This article provides a compact overview of the implicated chemicals and their modes of action. We also present the current level of evidence, linking exposure to these endocrine disrupting chemicals and obesity and its related diseases.

View PDFchevron_right
Obesity II: Establishing causal links between chemical exposures and obesity
Monica Lind

Biochemical Pharmacology

Obesity is a multifactorial disease with both genetic and environmental components. The prevailing view is that obesity results from an imbalance between energy intake and expenditure caused by overeating and insufficient exercise. We describe another environmental element that can alter the balance between energy intake and energy expenditure: obesogens. Obesogens are a subset of environmental chemicals that act as endocrine disruptors affecting metabolic endpoints. The obesogen hypothesis posits that exposure to endocrine disruptors and other chemicals can alter the development and function of the adipose tissue, liver, pancreas, gastrointestinal tract, and brain, thus changing the set point for control of metabolism. Obesogens can determine how much food is needed to maintain homeostasis and thereby increase the susceptibility to obesity. The most sensitive time for obesogen action is in utero and early childhood, in part via epigenetic programming that can be transmitted to future generations. This review explores the evidence supporting the obesogen hypothesis and highlights knowledge gaps that have prevented widespread acceptance as a contributor to the obesity pandemic. Critically, the obesogen hypothesis changes the narrative from curing obesity to preventing obesity. Many thousands of chemicals are used in commerce today, yet most health hazards have not been characterized. Chemical toxicants have several modes of action. These include specific or non-specific lethality, organ toxicity, genotoxicity, and mutagenicity through DNA sequence and structural alterations. They can also disrupt hormone levels or action, as with EDCs . EDCs have an array of key characteristics,

View PDFchevron_right
BPA exposure is related to metabolic changes in obese Saudi children
Sherif Abd-Alrahman

International journal of clinical and experimental pathology, 2017

BACKGROUND AND OBJECTIVE Bisphenol A (BPA) disturbs the metabolism in animals and humans through effecting endocrine system. The role of BPA in obesity is not studied well. Therefore, current study is conducted to investigate its association with childhood obesity. METHODS Using gas chromatography-mass spectrometry (GC-MS/MS) serum BPA level was measured in 177 (120 normal and 57 obese) Saudi children. RESULTS The analyses of the data revealed an elevated level of serum BPA, leptin, systolic blood pressure, triglyceride, insulin and vitamin D in obese children as compare to normal controls. An elevated serum BPA did not show association with increased vitamin D and insulin while positively associated with some of the key markers of obesity. BPA was also positively associated with laptin, insulin and diastolic blood pressure in individuals of both normal and obese groups but with little statistical differences. CONCLUSION Higher BPA level in obese children reveals that it may involve...

View PDFchevron_right

References (126)

  1. Grün, F. and B. Blumberg, Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Reviews in Endocrine and Metabolic Disorders, 2007. 8(2): p. 161- 171.
  2. Bergman, A., J.J. Heindel, S. Jobling, K.A. Kidd, and R.T. Zoeller, State of the science of endocrine disrupting chemicals -2012, UNEP/WHO, Editor 2013.
  3. Regnier, S.M. and R.M. Sargis, Adipocytes under assault: Environmental disruption of adipose physiology. Biochim Biophys Acta, 2013.
  4. Vos, J.G., E. Dybing, H.A. Greim, O. Ladefoged, C. Lambré, J.V. Tarazona, I. Brandt, and A.D. Vethaak, Health Effects of Endocrine- Disrupting Chemicals on Wildlife, with Special Reference to the European Situation. Crit Rev Toxicol, 2000. 30(1): p. 71-133.
  5. Vandenberg, L.N., T. Colborn, T.B. Hayes, J.J. Heindel, D.R. Jacobs, D.- H. Lee, T. Shioda, A.M. Soto, F.S. vom Saal, W.V. Welshons, R.T. Zoeller, and J.P. Myers, Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses. Endocr Rev, 2012. 33(3): p. 378-455.
  6. Melnick, R., G. Lucier, M. Wolfe, R. Hall, G. Stancel, G. Prins, M. Gallo, K. Reuhl, S.M. Ho, T. Brown, J. Moore, J. Leakey, J. Haseman, and M. Kohn, Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect, 2002. 110(4): p. 427-31.
  7. Barker, D.J.P. and C. Osmond, Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. The Lancet, 1986. 327(8489): p. 1077-1081.
  8. Barker, D.J.P., The origins of the developmental origins theory. Journal of Internal Medicine, 2007. 261(5): p. 412-417.
  9. Herbst, A.L., R.J. Kurman, R.E. Scully, and D.C. Poskanzer, Clear-Cell Adenocarcinoma of the Genital Tract in Young Females. New England Journal of Medicine, 1972. 287(25): p. 1259-1264.
  10. Harris, R.M. and R.H. Waring, Diethylstilboestrol-A long-term legacy. Maturitas, 2012. 72(2): p. 108-112.
  11. Titus-Ernstoff, L., R. Troisi, E.E. Hatch, J.R. Palmer, M. Hyer, R. Kaufman, E. Adam, K. Noller, and R.N. Hoover, Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES). Int J Androl, 2010. 33(2): p. 377-384.
  12. Palmer, J.R., L.A. Wise, S.J. Robboy, L. Titus-Ernstoff, K.L. Noller, A.L. Herbst, R. Troisi, and R.N. Hoover, Hypospadias in Sons of Women Exposed to Diethylstilbestrol In Utero. Epidemiology, 2005. 16(4): p. 583-586 10.1097/01.ede.0000164789.59728.6d.
  13. Dulloo, A.G., Energy balance and body weight homeostasis, in Clinical obesity in adults and children, P.G. Kopelman, I.D. Caterson, and W.H. Dietz, Editors. 2010, Wiley-Blackwell. p. 67-81.
  14. Chen, Y. and L. Qian, Association between lifetime stress and obesity in Canadians. Preventive Medicine, 2012. 55(5): p. 464-467.
  15. Tamashiro, K.L., R.R. Sakai, C.A. Shively, I.N. Karatsoreos, and L.P. Reagan, Chronic stress, metabolism, and metabolic syndrome. Stress, 2011. 14(5): p. 468-74.
  16. Kuo, L.E., J.B. Kitlinska, J.U. Tilan, L. Li, S.B. Baker, M.D. Johnson, E.W. Lee, M.S. Burnett, S.T. Fricke, R. Kvetnansky, H. Herzog, and Z. Zukowska, Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med, 2007. 13(7): p. 803-11.
  17. Rutters, F., H.K. Gonnissen, R. Hursel, S.G. Lemmens, E.A. Martens, and M.S. Westerterp-Plantenga, Distinct associations between energy balance and the sleep characteristics slow wave sleep and rapid eye movement sleep. Int J Obes, 2012.
  18. Gonnissen, H.K.J., T.C. Adam, R. Hursel, F. Rutters, S.P.M. Verhoef, and M.S. Westerterp-Plantenga, Sleep duration, sleep quality and body weight: Parallel developments. Physiology & Behavior, (0).
  19. Waye, M.M., New insights into how adenovirus might lead to obesity: An oxidative stress theory. Free Radic Res, 2011. 45(8): p. 880-7.
  20. Esposito, S., V. Preti, E. Nazzari, S. Consolo, and N. Principi, Is there a link between infection due to adenovirus 36 and childhood obesity? Pediatr Infect Dis J, 2012. 31(11): p. 1184-6.
  21. Hur, S.J., D.H. Kim, S.C. Chun, and S.K. Lee, Effect of adenovirus and influenza virus infection on obesity. Life Sciences, (0).
  22. Kallus, S.J. and L.J. Brandt, The Intestinal Microbiota and Obesity. Journal of Clinical Gastroenterology, 2012. 46(1): p. 16-24 10.1097/MCG.0b013e31823711fd.
  23. Boroni Moreira, A.P., T. Fiche Salles Teixeira, C.G.P.M. do, and R. de Cassia Goncalves Alfenas, Gut microbiota and the development of obesity. Nutr Hosp, 2012. 27(5): p. 1408-14.
  24. Balthazar, E. and M.R. de Oliveira, Differences in dietary pattern between obese and eutrophic children. BMC Research Notes, 2011. 4(1): p. 567.
  25. Grun, F. and B. Blumberg, Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord, 2007. 8(2): p. 161-71.
  26. Hatch, E.E., J.W. Nelson, R.W. Stahlhut, and T.F. Webster, Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int J Androl, 2010. 33(2): p. 324-32.
  27. Grün, F. and B. Blumberg, Endocrine disrupters as obesogens. Mol Cell Endocrinol, 2009. 304(1-2): p. 19-29.
  28. Janesick, A. and B. Blumberg, Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today, 2011. 93(1): p. 34-50.
  29. Lind, P.M., U. Risérus, S. Salihovic, B.v. Bavel, and L. Lind, An environmental wide association study (EWAS) approach to the metabolic syndrome. Environ Int, 2013. 55(0): p. 1-8.
  30. James, W.P., The epidemiology of obesity: the size of the problem. J Intern Med, 2008. 263(4): p. 336-52.
  31. Keith, S.W., D.T. Redden, P.T. Katzmarzyk, M.M. Boggiano, E.C. Hanlon, R.M. Benca, D. Ruden, A. Pietrobelli, J.L. Barger, K.R. Fontaine, C. Wang, L.J. Aronne, S.M. Wright, M. Baskin, N.V. Dhurandhar, M.C. Lijoi, C.M. Grilo, M. DeLuca, A.O. Westfall, and D.B. Allison, Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond), 2006. 30(11): p. 1585-94.
  32. Sorensen, T.I., Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Diabetes and health". Challenges in the study of causation of obesity. Proc Nutr Soc, 2009. 68(1): p. 43-54.
  33. Hansen, T., H. Ahlström, S. Söderberg, J. Hulthe, J. Wikström, L. Lind, and L. Johansson, Visceral adipose tissue, adiponectin levels and insulin resistance are related to atherosclerosis as assessed by whole-body magnetic resonance angiography in an elderly population. Atherosclerosis, 2009. 205(1): p. 163-167.
  34. Wronska, A. and Z. Kmiec, Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiologica, 2012. 205(2): p. 194-208.
  35. Ben-Jonathan, N., E.R. Hugo, and T.D. Brandebourg, Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol, 2009. 304(1-2): p. 49-54.
  36. Lilja, M., O. Rolandsson, M. Norberg, and S. Soderberg, The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance. Metab Syndr Relat Disord, 2012. 10(2): p. 143-51.
  37. Meier, U. and A.M. Gressner, Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem, 2004. 50(9): p. 1511-25.
  38. Farooqi, I.S., J.M. Keogh, S. Kamath, S. Jones, W.T. Gibson, R. Trussell, S.A. Jebb, G.Y. Lip, and S. O'Rahilly, Partial leptin deficiency and human adiposity. Nature, 2001. 414(6859): p. 34-5.
  39. Verhulst, P.J. and I. Depoortere, Ghrelin's second life: from appetite stimulator to glucose regulator. World J Gastroenterol, 2012. 18(25): p. 3183-95.
  40. Platonow, N.S., E.B. Meads, R.M. Liptrap, and F. Lotz, Effects of some commercial preparations of polychlorinated biphenyls in growing piglets. Can J Comp Med, 1976. 40(4): p. 421-8.
  41. Örberg, J., Effects of pure chlorobiphenyls (2,4',5-trichlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl) on the post-natal growth in mice. Acta Pharmacol Toxicol (Copenh), 1978. 42(4): p. 275-9.
  42. Raun, A.P. and R.L. Preston, History of diethylstilbestrol use in cattle. J. Anim. Sci, 2002(80): p. 1-7.
  43. Adedeji, O.B., E.J. Durhan, N. Garcia-Reyero, M.D. Kahl, K.M. Jensen, C.A. Lalone, E.A. Makynen, E.J. Perkins, L. Thomas, D.L. Villeneuve, and G.T. Ankley, Short-term study investigating the estrogenic potency of diethylstilbesterol in the fathead minnow (Pimephales promelas). Environ Sci Technol, 2012. 46(14): p. 7826- 35.
  44. Matsumura, F., The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochemical Pharmacology, 2009. 77(4): p. 608-626.
  45. Warner, M., P. Mocarelli, P. Brambilla, A. Wesselink, S. Samuels, S. Signorini, and B. Eskenazi, Diabetes, Metabolic Syndrome, and Obesity in Relation to Serum Dioxin Concentrations: The Seveso Women's Health Study. Environ Health Perspect, 2013. 121(8): p. 906-11.
  46. Rönn, M., L. Lind, B. van Bavel, S. Salihovic, K. Michaelsson, and P.M. Lind, Circulating levels of persistent organic pollutants associate in divergent ways to fat mass measured by DXA in humans. Chemosphere, 2011. 85(3): p. 335-43.
  47. Kim, M.J., V. Pelloux, E. Guyot, J. Tordjman, L.C. Bui, A. Chevallier, C. Forest, C. Benelli, K. Clement, and R. Barouki, Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells. Environ Health Perspect, 2012. 120(4): p. 508-14.
  48. Verhulst, S.L., V. Nelen, E.D. Hond, G. Koppen, C. Beunckens, C. Vael, G. Schoeters, and K. Desager, Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect, 2009. 117(1): p. 122-6.
  49. Dirinck, E., P.G. Jorens, A. Covaci, T. Geens, L. Roosens, H. Neels, I. Mertens, and L. Van Gaal, Obesity and Persistent Organic Pollutants: Possible Obesogenic Effect of Organochlorine Pesticides and Polychlorinated Biphenyls. Obesity, 2010.
  50. Rashid, C.S., L.G. Carter, B. Hennig, and K.J. Pearson, Perinatal Polychlorinated Biphenyl 126 Exposure Alters Offspring Body Composition. J Pediatr Biochem, 2013. 3(1): p. 47-53.
  51. Carson, R., Silent Spring1962, Boston: Houghton Mifflin Company.
  52. Bouwman, H., H. van den Berg, and H. Kylin, DDT and malaria prevention: addressing the paradox. Environ Health Perspect, 2011. 119(6): p. 744-7.
  53. U.S.DepartmentofHealth&HumanServices and NationalToxicologyProgram, Dichlorodiphenyltrichloroethane, in Rep Carcinog2011. p. 143-5.
  54. Rignell-Hydbom, A., J. Lidfeldt, H. Kiviranta, P. Rantakokko, G. Samsioe, C.-D. Agardh, and L. Rylander, Exposure to p,p′-DDE: A Risk Factor for Type 2 Diabetes. PLoS One, 2009. 4(10): p. e7503.
  55. Papoulias, D.M., S.A. Villalobos, J. Meadows, D.B. Noltie, J.P. Giesy, and D.E. Tillitt, In ovo exposure to o,p -DDE affects sexual development but not sexual differentiation in Japanese medaka (Oryzias latipes). Environ Health Perspect, 2003. 111(1): p. 29-32.
  56. Kelce, W.R., C.R. Lambright, L.E. Gray Jr, and K.P. Roberts, Vinclozolin andp,p′-DDE Alter Androgen-Dependent Gene Expression:In VivoConfirmation of an Androgen Receptor-Mediated Mechanism. Toxicology and Applied Pharmacology, 1997. 142(1): p. 192-200.
  57. Elobeid, M.A., M.A. Padilla, D.W. Brock, D.M. Ruden, and D.B. Allison, Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999-2002 data. Int J Environ Res Public Health, 2010. 7(7): p. 2988-3005.
  58. Karmaus, W., J.R. Osuch, I. Eneli, L.M. Mudd, J. Zhang, D. Mikucki, P. Haan, and S. Davis, Maternal levels of dichlorodiphenyl- dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occupational and Environmental Medicine, 2009. 66(3): p. 143-149.
  59. Roos, V., M. Ronn, S. Salihovic, L. Lind, B.V. Bavel, J. Kullberg, L. Johansson, H. Ahlstrom, and P.M. Lind, Circulating Levels of Persistent Organic Pollutants in Relation to Visceral and Subcutaneous Adipose Tissue by Abdominal MRI. Obesity (Silver Spring), 2012.
  60. Warner, M., R. Aguilar Schall, K.G. Harley, A. Bradman, D. Barr, and B. Eskenazi, In utero DDT and DDE exposure and obesity status of 7-year-old Mexican-American children in the CHAMACOS cohort. Environ Health Perspect, 2013. 121(5): p. 631-6.
  61. Howell Iii, G. and L. Mangum, Exposure to bioaccumulative organochlorine compounds alters adipogenesis, fatty acid uptake, and adipokine production in NIH3T3-L1 cells. Toxicology in Vitro, 2011. 25(1): p. 394-402.
  62. Gumy, C., C. Chandsawangbhuwana, A.A. Dzyakanchuk, D.V. Kratschmar, M.E. Baker, and A. Odermatt, Dibutyltin Disrupts Glucocorticoid Receptor Function and Impairs Glucocorticoid- Induced Suppression of Cytokine Production. PLoS One, 2008. 3(10): p. e3545.
  63. Morcillo, Y. and C. Porte, Evidence of Endocrine Disruption in the Imposex-Affected Gastropod Bolinus brandaris. Environmental Research, 1999. 81(4): p. 349-354.
  64. Grün, F. and B. Blumberg, Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor Signaling. Endocrinology, 2006. 147(6): p. s50-s55.
  65. Grün, F., H. Watanabe, Z. Zamanian, L. Maeda, K. Arima, R. Cubacha, D.M. Gardiner, J. Kanno, T. Iguchi, and B. Blumberg, Endocrine- Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates. Molecular Endocrinology, 2006. 20(9): p. 2141-2155.
  66. Inadera, H. and A. Shimomura, Environmental chemical tributyltin augments adipocyte differentiation. Toxicology Letters, 2005. 159(3): p. 226-234.
  67. Chamorro-Garcia, R., M. Sahu, R.J. Abbey, J. Laude, N. Pham, and B. Blumberg, Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ Health Perspect, 2013. 121(3): p. 359-66.
  68. Frias, J.P.G.L., P. Sobral, and A.M. Ferreira, Organic pollutants in microplastics from two beaches of the Portuguese coast. Marine Pollution Bulletin, 2010. 60(11): p. 1988-1992.
  69. Martins, J. and P. Sobral, Plastic marine debris on the Portuguese coastline: A matter of size? Marine Pollution Bulletin, 2011. 62(12): p. 2649-2653.
  70. Dodds, L., Synthetic oestrogenic agents without the phenanthrene nucleus. Nature, 1936. 137(996).
  71. vom Saal, F.S., S.C. Nagel, B.L. Coe, B.M. Angle, and J.A. Taylor, The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol, 2012. 354(1-2): p. 74-84.
  72. Alonso-Magdalena, P., A.B. Ropero, S. Soriano, M. García-Arévalo, C. Ripoll, E. Fuentes, I. Quesada, and Á. Nadal, Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol Cell Endocrinol, 2012. 355(2): p. 201-207.
  73. Vandenberg, L.N., P.A. Hunt, J.P. Myers, and F.S. Vom Saal, Human exposures to bisphenol A: mismatches between data and assumptions. Rev Environ Health, 2013. 28(1): p. 37-58.
  74. Rhomberg, L.R. and J.E. Goodman, Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: Has the case been made? Regulatory Toxicology and Pharmacology, 2012. 64(1): p. 130-133.
  75. Gioiosa, L., S. Parmigiani, F.S. vom Saal, and P. Palanza, The effects of bisphenol A on emotional behavior depend upon the timing of exposure, age and gender in mice. Hormones and Behavior, 2013. 63(4): p. 598-605.
  76. Vandenberg, L.N., M.V. Maffini, C. Sonnenschein, B.S. Rubin, and A.M. Soto, Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev, 2009. 30(1): p. 75-95.
  77. Geens, T., D. Aerts, C. Berthot, J.-P. Bourguignon, L. Goeyens, P. Lecomte, G. Maghuin-Rogister, A.-M. Pironnet, L. Pussemier, M.- L. Scippo, J. Van Loco, and A. Covaci, A review of dietary and non- 89.
  78. Rönn, M., J. Kullberg, H. Karlsson, J. Berglund, F. Malmberg, J. Örberg, L. Lind, H. Ahlström, and P.M. Lind, Bisphenol A exposure increases liver fat in juvenile fructose-fed Fischer 344 rats. Toxicology, 2013. 303(0): p. 125-132.
  79. Feige, J.N., L. Gelman, D. Rossi, V. Zoete, R. Metivier, C. Tudor, S.I. Anghel, A. Grosdidier, C. Lathion, Y. Engelborghs, O. Michielin, W. Wahli, and B. Desvergne, The endocrine disruptor monoethyl- hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem, 2007. 282(26): p. 19152-66.
  80. Hao, C., X. Cheng, J. Guo, H. Xia, and X. Ma, Perinatal exposure to diethyl-hexyl-phthalate induces obesity in mice. Front Biosci (Elite Ed), 2013. 5: p. 725-33.
  81. Lind, P.M., V. Roos, M. Ronn, L. Johansson, H. Ahlstrom, J. Kullberg, and L. Lind, Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women. Environ Health, 2012. 11: p. 21.
  82. Swan, S.H., K.M. Main, F. Liu, S.L. Stewart, R.L. Kruse, A.M. Calafat, C.S. Mao, J.B. Redmon, C.L. Ternand, S. Sullivan, and J.L. Teague, Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect, 2005. 113(8): p. 1056- 61.
  83. Stahlhut, R.W., E. van Wijngaarden, T.D. Dye, S. Cook, and S.H. Swan, Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect, 2007. 115(6): p. 876-82.
  84. Manikkam, M., R. Tracey, C. Guerrero-Bosagna, and M.K. Skinner, Plastics Derived Endocrine Disruptors (BPA, DEHP and DBP) Induce Epigenetic Transgenerational Inheritance of Obesity, Reproductive Disease and Sperm Epimutations. PLoS One, 2013. 8(1): p. e55387.
  85. Kolak, M., H. Yki-Järvinen, K. Kannisto, M. Tiikkainen, A. Hamsten, P. Eriksson, and R.M. Fisher, Effects of Chronic Rosiglitazone Therapy on Gene Expression in Human Adipose Tissue in Vivo in Patients with Type 2 Diabetes. Journal of Clinical Endocrinology & Metabolism, 2007. 92(2): p. 720-724.
  86. Emmett, E.A., F.S. Shofer, H. Zhang, D. Freeman, C. Desai, and L.M. Shaw, Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med, 2006. 48(8): p. 759-70.
  87. Halldorsson, T.I., D. Rytter, L.S. Haug, B.H. Bech, I. Danielsen, G. Becher, T.B. Henriksen, and S.F. Olsen, Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect, 2012. 120(5): p. 668-73.
  88. Hines, E.P., S.S. White, J.P. Stanko, E.A. Gibbs-Flournoy, C. Lau, and S.E. Fenton, Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol, 2009. 304(1-2): p. 97-105.
  89. Meggs, W.J. and K.L. Brewer, Weight gain associated with chronic exposure to chlorpyrifos in rats. J Med Toxicol, 2007. 3(3): p. 89- 93.
  90. Lassiter, T.L. and S. Brimijoin, Rats gain excess weight after developmental exposure to the organophosphorothionate pesticide, chlorpyrifos. Neurotoxicology and Teratology, 2008. 30(2): p. 125- 130.
  91. Lim, S., S.Y. Ahn, I.C. Song, M.H. Chung, H.C. Jang, K.S. Park, K.-U. Lee, Y.K. Pak, and H.K. Lee, Chronic Exposure to the Herbicide, Atrazine, Causes Mitochondrial Dysfunction and Insulin Resistance. PLoS One, 2009. 4(4): p. e5186.
  92. Hayes, T.B., L.L. Anderson, V.R. Beasley, S.R. de Solla, T. Iguchi, H. Ingraham, P. Kestemont, J. Kniewald, Z. Kniewald, V.S. Langlois, E.H. Luque, K.A. McCoy, M. Muñoz-de-Toro, T. Oka, C.A. Oliveira, F. Orton, S. Ruby, M. Suzawa, L.E. Tavera-Mendoza, V.L. Trudeau, A.B. Victor-Costa, and E. Willingham, Demasculinization and feminization of male gonads by atrazine: Consistent effects across vertebrate classes. The Journal of Steroid Biochemistry and Molecular Biology, 2011. 127(1-2): p. 64-73.
  93. Valvi, D., M.A. Mendez, R. Garcia-Esteban, F. Ballester, J. Ibarluzea, F. Goñi, J.O. Grimalt, S. Llop, L.S. Marina, E. Vizcaino, J. Sunyer, and M. Vrijheid, Prenatal exposure to persistent organic pollutants and rapid weight gain and overweight in infancy. Obesity, 2013: p. n/a-n/a.
  94. Smink, A., N. Ribas-Fito, R. Garcia, M. Torrent, M.A. Mendez, J.O. Grimalt, and J. Sunyer, Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatrica, 2008. 97(10): p. 1465-1469.
  95. Eggesbø, M., H. Stigum, M.P. Longnecker, A. Polder, M. Aldrin, O. Basso, C. Thomsen, J.U. Skaare, G. Becher, and P. Magnus, Levels of hexachlorobenzene (HCB) in breast milk in relation to birth weight in a Norwegian cohort. Environmental Research, 2009. 109(5): p. 559-566.
  96. Somm, E., V.M. Schwitzgebel, D.M. Vauthay, E.J. Camm, C.Y. Chen, J.P. Giacobino, S.V. Sizonenko, M.L. Aubert, and P.S. Huppi, Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology, 2008. 149(12): p. 6289-99.
  97. Huang, F., S. Wen, J. Li, Y. Zhong, Y. Zhao, and Y. Wu, The human body burden of polybrominated diphenyl ethers and their relationships with thyroid hormones in the general population in Northern China. Science of The Total Environment, 2014. 466- 467(0): p. 609-615.
  98. Lignell, S., M. Aune, P.O. Darnerud, A. Hanberg, S.C. Larsson, and A. Glynn, Prenatal exposure to polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) may influence birth weight among infants in a Swedish cohort with background exposure: a cross-sectional study. Environ Health, 2013. 12: p. 44.
  99. Flegal, K.M., M.D. Carroll, B.K. Kit, and C.L. Ogden, Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010. JAMA: The Journal of the American Medical Association, 2012. 307(5): p. 491-497.
  100. Carlsson, A.C., U. Riserus, G. Engstrom, J. Arnlov, O. Melander, K. Leander, B. Gigante, M.L. Hellenius, and U. de Faire, Novel and established anthropometric measures and the prediction of incident cardiovascular disease: a cohort study. Int J Obes, 2013.
  101. Jensen, M.N. and M. Ritskes-Hoitinga, How isoflavone levels in common rodent diets can interfere with the value of animal models and with experimental results. Laboratory Animals, 2007. 41(1): p. 1-18.
  102. Odum, J., H. Tinwell, K. Jones, J.P. Van Miller, R.L. Joiner, G. Tobin, H. Kawasaki, R. Deghenghi, and J. Ashby, Effect of Rodent Diets on the Sexual Development of the Rat. Toxicological Sciences, 2001. 61(1): p. 115-127.
  103. Sandau, C.D., A. Sjödin, M.D. Davis, J.R. Barr, V.L. Maggio, A.L. Waterman, K.E. Preston, J.L. Preau, D.B. Barr, L.L. Needham, and D.G. Patterson, Comprehensive Solid-Phase Extraction Method for Persistent Organic Pollutants. Validation and Application to the Analysis of Persistent Chlorinated Pesticides. Analytical Chemistry, 2002. 75(1): p. 71-77.
  104. Larsson, B., K. Svardsudd, L. Welin, L. Wilhelmsen, P. Bjorntorp, and G. Tibblin, Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed), 1984. 288(6428): p. 1401-4.
  105. Wang, Z., S.B. Heymsfield, Z. Chen, S. Zhu, and R.N. Pierson, Estimation of percentage body fat by dual-energy x-ray absorptiometry: evaluation by in vivo human elemental composition. Phys Med Biol, 2010. 55(9): p. 2619-35.
  106. Kullberg, J., C. von Below, L. Lonn, L. Lind, H. Ahlstrom, and L. Johansson, Practical approach for estimation of subcutaneous and visceral adipose tissue. Clin Physiol Funct Imaging, 2007. 27(3): p. 148-53.
  107. Marmugi, A., S. Ducheix, F. Lasserre, A. Polizzi, A. Paris, N. Priymenko, J. Bertrand-Michel, T. Pineau, H. Guillou, P.G.P. Martin, and L. Mselli-Lakhal, Low doses of bisphenol a induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology, 2012. 55(2): p. 395- 407.
  108. Jaichander, P., K. Selvarajan, M. Garelnabi, and S. Parthasarathy, Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. J Lipid Res, 2008. 49(10): p. 2142-8.
  109. Duvillard, L., G. Dautin, E. Florentin, A. Jeannin, J.P. Pais de Barros, L. Lagrost, J.M. Petit, P. Gambert, and B. Verges, Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive. J Clin Endocrinol Metab, 2009. 94(12): p. 4891-7.
  110. Dhooge, W., E. Den Hond, G. Koppen, L. Bruckers, V. Nelen, E. Van De Mieroop, M. Bilau, K. Croes, W. Baeyens, G. Schoeters, and N. Van Larebeke, Internal exposure to pollutants and body size in Flemish adolescents and adults: Associations and dose-response relationships. Environment International, 2010. 36(4): p. 330-337.
  111. Noth, R.H. and E.L. Mazzaferri, Age and the endocrine system. Clin Geriatr Med, 1985. 1(1): p. 223-50.
  112. Olsen, L., E. Lampa, D.A. Birkholz, L. Lind, and P.M. Lind, Circulating levels of bisphenol A (BPA) and phthalates in an elderly population in Sweden, based on the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS). Ecotoxicol Environ Saf, 2012. 75(1): p. 242-8.
  113. Wei, J., Y. Lin, Y. Li, C. Ying, J. Chen, L. Song, Z. Zhou, Z. Lv, W. Xia, X. Chen, and S. Xu, Perinatal Exposure to Bisphenol A at Reference Dose Predisposes Offspring to Metabolic Syndrome in Adult Rats on a High-Fat Diet. Endocrinology, 2011. 152(8): p. 3049-3061.
  114. Trasande, L., T.M. Attina, and J. Blustein, Association between urinary bisphenol a concentration and obesity prevalence in children and adolescents. JAMA, 2012. 308(11): p. 1113-1121.
  115. Wang, T., M. Li, B. Chen, M. Xu, Y. Xu, Y. Huang, J. Lu, Y. Chen, W. Wang, X. Li, Y. Liu, Y. Bi, S. Lai, and G. Ning, Urinary Bisphenol A (BPA) Concentration Associates with Obesity and Insulin Resistance. Journal of Clinical Endocrinology & Metabolism, 2012. 97(2): p. E223-E227.
  116. Bhandari, R., J. Xiao, and A. Shankar, Urinary Bisphenol A and Obesity in US Children. American Journal of Epidemiology, 2013.
  117. Klok, M.D., S. Jakobsdottir, and M.L. Drent, The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obesity Reviews, 2007. 8(1): p. 21-34.
  118. Swarbrick, M.M. and P.J. Havel, Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord, 2008. 6(2): p. 87-102.
  119. Cummings, D.E., Ghrelin and the short-and long-term regulation of appetite and body weight. Physiology & Behavior, 2006. 89(1): p. 71-84.
  120. Sowers, M.R., R.P. Wildman, P. Mancuso, A.D. Eyvazzadeh, C.A. Karvonen-Gutierrez, E. Rillamas-Sun, and M.L. Jannausch, Change in adipocytokines and ghrelin with menopause. Maturitas, 2008. 59(2): p. 149-157.
  121. Speakman, J.R. and S. O'Rahilly, Fat: an evolving issue. Dis Model Mech, 2012. 5(5): p. 569-73.
  122. Holtcamp, W., Obesogens: an environmental link to obesity. Environ Health Perspect, 2012. 120(2): p. a62-8.
  123. Schug, T.T., R. Abagyan, B. Blumberg, T.J. Collins, D. Crews, P.L. DeFur, S.M. Dickerson, T.M. Edwards, A.C. Gore, L.J. Guillette, T. Hayes, J.J. Heindel, A. Moores, H.B. Patisaul, T.L. Tal, K.A. Thayer, L.N. Vandenberg, J.C. Warner, C.S. Watson, F.S. vom Saal, R.T. Zoeller, K.P. O'Brien, and J.P. Myers, Designing endocrine disruption out of the next generation of chemicals. Green Chemistry, 2013. 15(1): p. 181-198.
  124. Vimaleswaran, K.S. and R.J.F. Loos, Progress in the genetics of common obesity and type 2 diabetes. Expert Reviews in Molecular Medicine, 2010. 12: p. e7.
  125. Baillie-Hamilton, P.F., Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med, 2002. 8(2): p. 185-92.
  126. Lee, D.H., L. Lind, D.R. Jacobs, Jr., S. Salihovic, B. van Bavel, and P.M. Lind, Associations of persistent organic pollutants with abdominal obesity in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Environ Int, 2012. 40: p. 170-8.

Related papers

Obesity and Environmental Pollutants
Journal of Diabetes and Obesity

Ommega online publishers, 2018

Obesity is a global health problem in recent years. Adipose tissue was known as a storage tissue increasing with rise of the body mass index the indicator of obesity. The endocrine functions of adipose tissue might contribute to obesity, diabetes mellitus, cancer and infertility. Many environmental chemicals affect actions of hormones so these chemicals have been defined as endocrine-disrupting chemicals(EDCs) or endocrine disruptors. With the increase in production of EDCs in the world parallels the global obesity prevalence increases. The reported rise in obesity of children under 2 years of age is also suggestive of alterations during development. In early life EDCs exposure can influence epigenetic programming of obesity. These pollutants can pass from mother to fetus via placenta and breast feeding. Some obesogens are found in nature such as phytoestrogens and the others are mostly synthetic chemicals. These chemicals commonly found in pesticides /herbicides, industrial and household products, plastics detergents and personal care products. These substances are defined persistant organic pollutant (POPs) and they accumulate in adipose tissue. Common EDSs are Tributyltin (TBT), 4-Nonylphenol used in industry, persistent organochlorines (POPs) used in agriculture industry, diethylstilboestrol (DES) as a pharmaceutical, bisphenol A (BPA) and phthalates used in plastics, parabens as preservatives, phytoestrogens in edible plants, polybrominated diphenylethers (PBDEs) as flame retardants. We searched current literature with the key words: obesogens, POPs, endocrine disruptors in pubmed and filtered the results with articles in recent 5 years. This mini reviewprovides current experience about association between obesity and endocrine disrupting chemicals.

View PDFchevron_right
The Role of Persistent Organic Pollutants in Obesity: A Review of Laboratory and Epidemiological Studies
Anatoly Skalny

Toxics

Persistent organic pollutants (POPs) are considered as potential obesogens that may affect adipose tissue development and functioning, thus promoting obesity. However, various POPs may have different mechanisms of action. The objective of the present review is to discuss the key mechanisms linking exposure to POPs to adipose tissue dysfunction and obesity. Laboratory data clearly demonstrate that the mechanisms associated with the interference of exposure to POPs with obesity include: (a) dysregulation of adipogenesis regulators (PPARγ and C/EBPα); (b) affinity and binding to nuclear receptors; (c) epigenetic effects; and/or (d) proinflammatory activity. Although in vivo data are generally corroborative of the in vitro results, studies in living organisms have shown that the impact of POPs on adipogenesis is affected by biological factors such as sex, age, and period of exposure. Epidemiological data demonstrate a significant association between exposure to POPs and obesity and obes...

View PDFchevron_right
Obesity and Persistent Organic Pollutants: Possible Obesogenic Effect of Organochlorine Pesticides and Polychlorinated Biphenyls
Hugo Neels

Obesity, 2011

View PDFchevron_right
Endocrine-disrupting chemicals and obesity development in humans: A review
B. Heitmann

Obesity Reviews, 2011

This study reviewed the literature on the relations between exposure to chemicals with endocrine-disrupting abilities and obesity in humans. The studies generally indicated that exposure to some of the endocrine-disrupting chemicals was associated with an increase in body size in humans. The results depended on the type of chemical, exposure level, timing of exposure and gender. Nearly all the studies investigating dichlorodiphenyldichloroethylene (DDE) found that exposure was associated with an increase in body size, whereas the results of the studies investigating polychlorinated biphenyl (PCB) exposure were depending on dose, timing and gender. Hexachlorobenzene, polybrominated biphenyls, betahexachlorocyclohexane, oxychlordane and phthalates were likewise generally associated with an increase in body size. Studies investigating polychlorinated dibenzodioxins and polychlorinated dibenzofurans found either associations with weight gain or an increase in waist circumference, or no association. The one study investigating relations with bisphenol A found no association. Studies investigating prenatal exposure indicated that exposure in utero may cause permanent physiological changes predisposing to later weight gain. The study findings suggest that some endocrine disruptors may play a role for the development of the obesity epidemic, in addition to the more commonly perceived putative contributors.

View PDFchevron_right
Life-Time Environmental Chemical Exposure and Obesity: Review of Epidemiological Studies Using Human Biomonitoring Methods
Nayan Mohanto

Frontiers in Endocrinology, 2021

The exponential global increase in the incidence of obesity may be partly attributable to environmental chemical (EC) exposure. Humans are constantly exposed to ECs, primarily through environmental components. This review compiled human epidemiological study findings of associations between blood and/or urinary exposure levels of ECs and anthropometric overweight and obesity indices. The findings reveal research gaps that should be addressed. We searched MEDLINE (PubMed) for full text English articles published in 2006–2020 using the keywords “environmental exposure” and “obesity”. A total of 821 articles were retrieved; 102 reported relationships between environmental exposure and obesity indices. ECs were the predominantly studied environmental exposure compounds. The ECs were grouped into phenols, phthalates, and persistent organic pollutants (POPs) to evaluate obesogenic roles. In total, 106 articles meeting the inclusion criteria were summarized after an additional search by ea...

View PDFchevron_right

Related topics

  • Medicine
    • 580 California St., Suite 400
    San Francisco, CA, 94104
    © 2025 Academia. All rights reserved